A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 150
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MS
Long Form : median survival
No. Year Title Co-occurring Abbreviation
2019 Efficacy of chemoradiotherapy combined with bevacizumab in patients with nasopharyngeal carcinoma: A comparative study. NSE, PFS
2019 Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA). BM, DS-GPA, GI
2019 Glioblastoma Multiforme in the over 70's: "To treat or not to treat with radiotherapy?" GBM, HR, RT
2019 Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress? BM, GI, GPA, KPS, TPDBM
2018 Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion. OS, RT
2018 Combining ultrasound and intratumoral administration of doxorubicin-loaded microspheres to enhance tumor cell killing. DOX, PLGA, US
2018 Exploration of a F(ab')2 Fragment as the Targeting Agent of alpha-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy. i.p, i.v, TAT
2018 PROGRAD - An observational study of the prognosis of inpatients evaluated for palliative radiotherapy. NRF, PPI, RT
2018 Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study. IDH1mut, MGMTmeth
10  2018 Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins. AT, NAT, NCDB
11  2018 [The Devascularisation Procedure for the Treatment of Fundic and Oesophageal Varices in Portal Hypertension - a Retrospective Analysis of 55 Cases]. ---
12  2017 5-aza-2',2'-Difluoro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer. HR, WT
13  2017 A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update. DFS, OS, PDAC
14  2017 An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland. PM
15  2017 Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. GBM, OS
16  2017 Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis. CRT, CT, HR, NCDB, uEHCC
17  2017 Estimating prognosis at the time of repeat whole brain radiation therapy for multiple brain metastases: The reirradiation score. CI, re-RT, RPA, WBRT
18  2017 Impact of interim progression during the surgery-to-radiotherapy interval and its predictors in glioblastoma treated with temozolomide-based radiochemotherapy. PD, RT, SRI
19  2017 Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer. CRT, CT, HR, LAPC, NCDB
20  2017 Multiple Myeloma with Advanced Bone Disease and Low Tumor Burden - Different Clinical Presentation but Similar Outcome after Bortezomib-Based Therapy and Radiotherapy. EFS, MBD, MF-MM, MM
21  2017 Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status. IDH1, MGMT, RPA
22  2017 Overall Survival in Spine Myeloma Metastases: Difficulties in Predicting With Prognostic Scores. ISS, MM, SD
23  2017 Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection? CI, HCC, HR, LT
24  2017 Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma. BL, CT, LA
25  2017 The effectiveness of radiotherapy for leukemia cutis. CRR, DOLC, LC, RT
26  2017 The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases. ---
27  2016 IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy. GBM, KPS, MGMT, psPD, TMZ
28  2016 Prognostic stratification and nomogram for survival prediction in hepatocellular carcinoma patients treated with radiotherapy for lymph node metastasis. HCC, HR, LN, RT
29  2016 The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases. BM, COD, L-adeno, TKI
30  2016 Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. DM, PT
31  2016 [Multidisciplinary treatment and survival analysis for 497 cases of pancreatic cancer with liver metastases]. CA, KPS, PCLM
32  2015 Association of educational levels with survival in Indian patients with cancer of the uterine cervix. ---
33  2015 Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution. GBM, PFS, RT
34  2015 Extended thymectomy including lung-sparing pleurectomy for the treatment of thymic malignancies with pleural spread. extended surgery, WHO
35  2015 Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta - A population-based study. C-statistic, HR, NSCLC, OS, SBRT
36  2015 Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. BCLC, BSC, HCC, LRT, MELD, PST
37  2015 Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands. CRC, CRS, HIPEC, PC
38  2015 [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases]. NSCLC
39  2014 Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin. CIs, CIS, EHBD, HGD, IC, MPDM
40  2014 Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial. DFS, NSCLC, OS, POCRT, POCT
41  2014 Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide. Gy, RT, TMZ
42  2014 Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis. BM, CIs, HRs, NSCLC, ORs, OS, PCI, RR
43  2014 Risk of treatment related death and febrile neutropaenia with first line palliative chemotherapy for de novo metastatic breast cancer in clinical practice in a middle resource country. FEC, FN, MBC, TRD, UMMC
44  2014 Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. CRLM, EHD, OS
45  2014 Thoracic reirradiation for lung cancer: a literature review and practical guide. LC, OS, re-RT
46  2014 [Analysis of initial treatment only by linac-based stereotactic radiosurgery for a metastatic brain tumor from non-small cell lung cancer]. KPS, NSCLC, RPA, RRDS, SRS, TCR, WBRT
47  2013 A reliable risk score for stage IV esophagogastric cancer. EGC
48  2013 Acute lymphoblastic leukemia experience: epidemiology and outcome of two different regimens. ALL, CR, CRD, KHCC
49  2013 Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb. mAbs, RIT
50  2013 Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature. DSRCT, TTP
51  2013 Evaluation of platinum chemotherapy in combination with HER2-targeted alpha-particle radiation. LET
52  2013 Improved long-term survival after esophagectomy for esophageal cancer: influence of epidemiologic shift and neoadjuvant therapy. AC, LNR, RR
53  2013 Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer. MBO, TPN
54  2013 Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections. EPP, MCR, mo, MPM, RP
55  2012 Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. 5FU-RT, PP
56  2012 Low dose palliative radiotherapy for splenomegaly in hematologic disorders. CLL, ML, MPD, PSI, SM
57  2012 Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma. CSP
58  2012 [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements]. AML, CR, D-FISH, RT-PCR
59  2011 Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study. OS
60  2011 Glioblastoma: patterns of recurrence and efficacy of salvage treatments. RT, TMZ, TTP
61  2011 Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy. CSP, HR
62  2011 Population-based outcomes after whole brain radiotherapy and re-irradiation in patients with metastatic breast cancer in the trastuzumab era. BM, BRT, HER2, OS, RPA, SRS
63  2011 Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. CI, PC
64  2011 Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. ADC, PRM, rCBV
65  2011 [Evaluation of the efficacy of bronchial arterial infusion chemotherapy for the treatment of central non-small cell lung cancer]. BAI
66  2010 Characterization and outcomes of infratentorial malignant glioma: a population-based study using the Surveillance Epidemiology and End-Results database. RT, SEER
67  2010 Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. CRPC, CRS, HIPEC, PSDS
68  2010 Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. CI, RCC
69  2010 Race and ethnicity correlate with survival in patients with gastric adenocarcinoma. CI, HR
70  2010 Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. CI, HCC, HR, SEER, UNOS
71  2010 Up-front temozolomide in elderly patients with glioblastoma. PFS, RT, TMZ
72  2010 [Efficacy and safety of erlotinib as monotherapy for advanced non-small cell lung cancer]. AEs, CI, EGFR, NSCLC, OS, PFS
73  2010 [The efficacy and safety of pemetrexed as monotherapy for Chinese patients with advanced non-small cell lung cancer]. AEs, NSCLC, PFS
74  2009 Disparities in gastric cancer outcomes among Asian ethnicities in the USA. CI, HR
75  2009 Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis. mAbs
76  2009 p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. OS, PFS, SNP
77  2009 Population-based study of pseudoprogression after chemoradiotherapy in GBM. GBM, TMZ
78  2009 Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. NSCLC, OS, SBRT
79  2009 [The prognostic value of a modified WPSS based on routine laboratory parameters in patients with myelodysplastic syndromes: a preliminary result]. MCH, MCV, MDS, N-ALP, PS
80  2008 A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma. HCC, pts
81  2008 Antitumor activity of platinum(II) complexes with histamine and radioiodinated histamine in a transplantable murine adenocarcinoma model. GDFs, MA
82  2008 Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies. DSS, RCC, UISS
83  2008 Evaluation of efficacy and safety of gefitinib as monotherapy in Chinese patients with advanced non-small cell lung cancer and very poor performance status. AEs, PFS, PS
84  2008 Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. ANITA, NSCLC, PORT
85  2008 Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. DFS, IC, LEC, OS, P-CTRT
86  2008 Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer. AUC, NSCLC, TTP
87  2008 [Efficacy and safety of gefitinib in maintenance therapy for patients with advanced non-small cell lung cancer]. NSCLC, PFS
88  2008 [Transcatheter treatment of liver metastases from breast cancer]. HAI, HAOC
89  2007 Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancer. ---
90  2007 Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study. AGC, CORR, FLAGS, KPS, TTP
91  2007 Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy. ECOG, GBM, RT, TMZ
92  2007 Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). CRT, NSCLC, OS, PFS
93  2007 Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599. ECOG, NSCLC, OS, PS
94  2006 An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study. AGAs, ORR, OS, TTP
95  2006 Cardiac and skin xenograft survival in different recipient mouse strains. KO
96  2005 Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients. 5-year SR, CT, NSCLC, pts, RT
97  2005 Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas. ARL, EFS
98  2005 Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer. BSC, MIC, RR
99  2005 Influence of diabetes on the survival of patients hospitalized with heart failure: a 12-year study. DM, HF, LVSF
100  2005 Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer. CI, EAP, NSCLC, PS